Should You Hold Kinnate Biopharma Inc (KNTE) Stock Thursday Morning?

Thursday, November 16, 2023 06:45 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Kinnate Biopharma Inc (KNTE) Stock Thursday Morning?

Kinnate Biopharma Inc (KNTE) is down Thursday morning, with the stock losing -100.00% in pre-market trading to . KNTE's short-term technical score of 73 indicates that the stock has traded more bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, the stock ranks higher than 82% of stocks. Kinnate Biopharma Inc has risen 92.31% over the past month, closing at $1.21 on October 19. During this period of time, the stock fell as low as $1.07 and as high as $1.61. KNTE has an average analyst recommendation of Buy. The company has an average price target of $6.58.

KNTE has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on KNTE!

See Full KNTE Report

Kinnate Biopharma Inc has a Long-Term Technical rank of 69. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 31% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, KNTE ranks better than 132% of stocks.

Important Dates for Investors in KNTE:

-Kinnate Biopharma Inc is set to release earnings on 2024-02-07. Over the last 12 months, the company has reported EPS of $-2.82. -We do not have a set dividend date for Kinnate Biopharma Inc at this time. Click Here To Get The Full Report on Kinnate Biopharma Inc (KNTE)